Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview
about
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007Persistence of low drug treatment coverage for injection drug users in large US metropolitan areasMethadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, CanadaDecrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island."We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.HIV-infected patients and treatment outcomes: an equivalence study of community-located, primary care-based HIV treatment vs. hospital-based specialty care in the Bronx, New YorkOngoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy.The relationship between injection and noninjection drug use and HIV disease progression.Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.Enhanced HIV testing, treatment, and support for HIV-infected substance users.Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users.Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-AnalysisImpact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.Seroprevalence of Human Immunodeficiency Virus and the rising epidemic of Human Immunodeficiency Virus among injecting drug users of district Patiala.The unrealized potential of addiction science in curbing the HIV epidemicMedication-taking self-efficacy and medication adherence among HIV-infected cocaine users.Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in ChinaHarm reduction interventions in HIV care: a qualitative exploration of patient and provider perspectives.Second-Line HIV Therapy Outcomes and Determinants of Mortality at the Largest HIV Referral Center in Southern Vietnam.Informed recruitment in partner studies of HIV transmission: an ethical issue in couples researchCombined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York City.Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia.Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center.Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.Exploring the role of an unsanctioned, supervised peer driven injection facility in reducing HIV and hepatitis C infections in people that require assistance during injection.Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada.Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007
P2860
Q28533642-053E24C1-BFB9-4247-8801-98BD7B0475E7Q30496986-919CC5D3-3559-44CE-9CF0-632D39B273E9Q33761440-A569C122-FD04-4891-AC5F-0B76B423BBB1Q34009387-8B7B3D76-5C1D-484F-A253-C2FF4F612CD1Q34113807-3C460866-315E-4A0B-9544-64456E765AC5Q34188736-9B34DDB7-0415-4A3B-95BF-B0387A267DF5Q34424535-B8EBB476-B041-4446-8E3D-6006A3304EC7Q34735099-76A44E99-A2D8-45A8-8365-700A835CF17FQ35032433-0B33D401-95E6-495D-92DD-44DACB3A5DC3Q35078732-BB55277B-2825-480D-A0CC-AED5F524C11CQ35253978-468E1171-C336-454D-9722-5C56C385B2FDQ35737423-22F0EC53-3032-4C96-A447-F9458EE20146Q35855263-6C6F5A80-5596-478D-B07D-04EC868E3F92Q35966865-99EDB2AA-C9B1-47AA-B4A3-F3E1AE52C166Q36061620-7CB1C922-152B-4A06-8E82-0E8222C66D63Q36167178-CF393DA1-DE47-43AB-8759-C5CBA8E500D3Q36321356-CB9447EC-F79F-4C5C-AA18-8A624CC3EE7BQ36460643-93DB65B7-ADC0-47C0-8101-01A5BAF19402Q36639722-DFA6D3DC-7CB5-4C4C-AA3E-A6CCBEE6CF9CQ36706986-5457C422-B643-4446-A24B-FD7E03E79A69Q36826390-D821FF79-D4AD-48F4-9A5E-C930CD1CCAAEQ37176147-6923EBB7-51FB-4723-B3C9-1FFA4EFC8504Q37362448-8A086B02-C4F5-44F6-A5A7-EEA3CF8C8F51Q37626445-E866EB01-1B5C-4D75-9685-4801EDA4897BQ37697607-2B902696-3951-4B96-B9A4-8200175EA7D3Q40477509-AB6BBD85-13F7-47BA-ADA6-56D49559B0A0Q41187933-AD82BA5C-06A3-432F-9022-0ADC72416985Q45958430-FDCD89C5-0591-4646-BFB3-BE21A9D2AF30Q47163239-37A39F00-912E-428D-8864-D304B82AC38EQ47582376-2E30C33F-ACF5-4E09-8D71-75E61427A731Q57170187-95CC424B-0C48-4C47-9746-94880F7C3B05
P2860
Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antiretroviral HIV treatment a ...... rs: an evidence-based overview
@ast
Antiretroviral HIV treatment a ...... rs: an evidence-based overview
@en
type
label
Antiretroviral HIV treatment a ...... rs: an evidence-based overview
@ast
Antiretroviral HIV treatment a ...... rs: an evidence-based overview
@en
prefLabel
Antiretroviral HIV treatment a ...... rs: an evidence-based overview
@ast
Antiretroviral HIV treatment a ...... rs: an evidence-based overview
@en
P2860
P1476
Antiretroviral HIV treatment a ...... rs: an evidence-based overview
@en
P2093
France Lert
Michel D Kazatchkine
P2860
P304
P356
10.1016/J.DRUGPO.2007.05.002
P577
2007-07-17T00:00:00Z